TraceLink and Optel Vision Collaborate for End-to-End Pharmaceutical Serialization, ePedigree and Global Track & Trace Solution

Pharmaceutical companies and CMO/CPO supply partners can confidently meet all global track and trace regulations from the H.R. 3204 Drug Quality and Security Act and California ePedigree to China, Argentina and Brazil and other serialization compliance laws through a new TraceLink – Optel Vision partnership. The TraceLink Life Sciences Cloud, integrated to Optel Vision's TrackSafe LineMaster packaging and line management systems, enables end-to-end control of serialization from packaging line to enterprise and global supply network, reducing cost, risk and time-to-compliance.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Global, cloud-based track and trace compliance platform

TraceLink Life Sciences Cloud

Wakefield MA, Quebec City Qc (PRWEB) November 11, 2013

TraceLink Inc., the leader in global pharmaceutical track and trace and supply network performance solutions, and Optel Vision, world track and trace solution provider, today announced a collaboration to deliver integrated serialization, ePedigree and traceability solutions for the global pharmaceutical supply chain. Working together, TraceLink and Optel Vision enable pharmaceutical companies and CMO/CPO supply partners to confidently meet all global track and trace regulations from the H.R. 3204 Drug Quality and Security Act and California ePedigree to China, Argentina, Brazil and other global serialization requirements.

The TraceLink Life Sciences Cloud’s global track and trace platform, integrated with Optel Vision’s TrackSafeTM LineMasterTM packaging and line management systems, enables end-to-end control of serialization activities from packaging line to enterprise and supply network coupled with integrated management of ePedigree and traceability reporting requirements.

Pharmaceutical companies and external supply partners benefit with:

  •     Centralized serialization information management from serial number provisioning to serial number usage as products are packaged and distributed across diverse regulatory environments
  •     Full serialized operations and inventory management for commissioning, aggregation, rework, exception processing and other activities from packaging line to warehouse and distribution center
  •     Integrated, seamless connectivity between track and trace solutions for ePedigree, supply chain traceability and government reporting solutions at the network level with serialization activities at the line, site and enterprise level

“Serialization is now a global compliance requirement, driving companies to think differently about their supply chain networks, business processes and IT architectures,” said Shabbir Dahod, President and CEO of TraceLink. “Diverse track and trace regulations across dozens of countries will impact 75 percent of the global drug supply by 2017, requiring the establishment of a serialization and traceability control tower that delivers the global visibility and flexible data exchange needed at all levels from line to network. We are excited to partner with a noted packaging and serialization leader like Optel Vision to deliver a comprehensive track and trace solution that reduces risk and decreases time-to-compliance.”

“The relationship between Optel Vision and Tracelink brings a robust solution that works seamlessly between each other from the packaging line up to the supply chain. This association is a leading step in our continuous efforts to help the pharmaceutical industry and distributors to improve patient safety and comply with the actual and upcoming regulations,” said Louis Roy, President of Optel Vision.

Diversified pharmaceutical companies, virtual biopharmas and contract packaging sites using Optel Vision’s extensive packaging line solutions will gain plug-and-play integration to the TraceLink Life Sciences Cloud through standardized connectors for serial number exchange, serialization event management and traceability reporting. The combined global compliance platform eliminates the risk of extensive software customization, the cost of point-to-point network integration and the ongoing transaction fees created by traditional serialization and traceability approaches.

To learn more about how TraceLink and Optel Vision can help ensure your global track and trace compliance, visit tracelink.com or optelvision.com

About TraceLink
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, enables global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient for our customers through a single connection to the TraceLink Network. Winner of numerous awards including the CIO 100, Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the global supply chain to comply with global track and trace regulations and improve performance in pharmaceutical production and distribution. For more information on TraceLink and our solutions, visit tracelink.com or follow us on LinkedIn.

TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. Our mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. We have built a deeply engaged community among the extraordinary teams in our network to spread ideas and opportunities. We are privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit us in New York City or online at firstmarkcap.com and @FirstMarkCap.

About Optel Vision
As a leader in Track & Trace and vision solutions, Optel Vision can be easily distinguished from the competition by our “real” turnkey offering since we provide all of the components and all of the services required to deploy the proper solution. We take complete responsibility for the successful implementation from the design to the validation. This is why, for over two decades, hundreds of pharmaceutical companies around the globe have trusted Optel Vision’s highly reliable automated vision systems to significantly reduce health risks associated with mislabeled products, dosage errors and product mix-ups. Optel Vision’s continuous investment in researching new cutting edge technologies guarantees that our customers receive the most innovative solutions to meet their challenging needs. Our vision solution's guarantee of success is founded on our strong project-oriented processes, based on GAMP guidelines, which ensures we meet all requirements within the shortest deployment time and deliver a validation-ready system. For more information on Optel Vision and our solutions, visit optelvision.com.


Contact